Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9

Anesthesiology

Volumn 117, Issue 2, 2012, Pages 293-301

  Müller Edenborn, Björn ^a,b   Roth Z'Graggen, Birgit ^a   Bartnicka, Kamila ^a   Borgeat, Alain ^a   Hoos, Alexandra ^b   Borsig, Lubor ^b   Beck Schimmer, Beatrice ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; DESFLURANE; GELATINASE B; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SEVOFLURANE;

ARTICLE; CANCER CELL; CANCER INVASION; CELL ISOLATION; CELL MIGRATION; CELL STIMULATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; ZYMOGRAPHY;

ANESTHETICS, INHALATION; COLORECTAL NEOPLASMS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; ISOFLURANE; MATRIX METALLOPROTEINASE 9; METHYL ETHERS; RECEPTORS, INTERLEUKIN-8B; REPERFUSION INJURY; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 84864281663     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182605df1     Document Type: Article

References (49)

1. Chari R: Colorectal Cancer Metastatic to the Liver: Resection and Intraarterial Chemotherapy. In: Cameron JL, ed. Current Surgical Therapy, 7th ed. St. Louis: Mosby; 2001, pp 375-80.
2. Guller U, Zajac P, Schnider A, Bösch B, Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U, Harder F, Heberer M, Marti WR: Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 2002; 236:768-75.
3. Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S: Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000; 232:58-65.
4. Doi K, Horiuchi T, Uchinami M, Tabo T, Kimura N, Yokomachi J, Yoshida M, Tanaka K: Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res 2002; 105:243-7.
5. Ku Y, Kusunoki N, Shiotani M, Maeda I, Iwasaki T, Tominaga M, Kitagawa T, Fukumoto T, Suzuki Y, Kuroda Y: Stimulation of haematogenous liver metastases by ischaemia-reperfusion in rats. Eur J Surg 1999; 165:801-7.
6. Yoshida M, Horiuchi T, Uchinami M, Tabo T, Kimura N, Yokomachi J, Doi K, Nakamura T, Tamagawa K, Tanaka K: Intermittent hepatic ischemia-reperfusion minimizes liver metastasis in rats. J Surg Res 2003; 111:255-60.
7. Nicoud IB, Jones CM, Pierce JM, Earl TM, Matrisian LM, Chari RS, Gorden DL: Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Res 2007; 67:2720-8.
8. Nagase H, Woessner JF Jr: Matrix metalloproteinases. J Biol Chem 1999; 274:21491-4.
9. Fidler IJ: Molecular biology of cancer: Invasion and metastasis. In: DeVita VT, ed. Cancer: Principles and Practise of Oncology, 5th ed. Philadelphia: Lippincott-Raven; 1997, pp 135-52.
10. Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S, Syrjänen K, Collan Y, Pyrhönen S: MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest 2010; 28:38-43.
11. Buhmeida A, Bendardaf R, Hilska M, Collan Y, Laato M, Syrjänen S, Syrjänen K, Pyrhönen S: Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma. J Gastrointest Cancer 2009; 40:91-7.
12. Chakrabarti S, Patel KD: Regulation of matrix metalloproteinase-9 release from IL-8-stimulated human neutrophils. J Leukoc Biol 2005; 78:279-88.
13. Inci I, Erne B, Arni S, Jungraithmayr W, Inci D, Hillinger S, Vogt P, Leskosek B, Weder W: Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. J Heart Lung Transplant 2010; 29:1293-301.
14. Kukielka GL, Smith CW, LaRosa GJ, Manning AM, Mendoza LH, Daly TJ, Hughes BJ, Youker KA, Hawkins HK, Michael LH: Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995; 95:89-103.
15. Sekido N, Mukaida N, Harada A, Nakanishi I, Watanabe Y, Matsushima K: Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 1993; 365:654-7.
16. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA: A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008; 248:909-18.
17. Heindl B, Reichle FM, Zahler S, Conzen PF, Becker BF: Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology 1999; 91:521-30.
18. Nader ND, Li CM, Khadra WZ, Reedy R, Panos AL: Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth 2004; 18:269-74.
19. de Rossi LW, Horn NA, Buhre W, Gass F, Hutschenreuter G, Rossaint R: The effect of isoflurane on neutrophil selectin and beta(2)-integrin activation in vitro. Anesth Analg 2002; 95:583-7.
20. Fröhlich D, Rothe G, Schwall B, Schmid P, Schmitz G, Taeger K, Hobbhahn J: Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide FMLP. Br J Anaesth 1997; 78:718-23.
21. Möbert J, Zahler S, Becker BF, Conzen PF: Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology 1999; 90:1372-81.
22. Roos D, de Boer M: Purification and cryopreservation of phagocytes from human blood. Methods Enzymol 1986; 132: 225-43.
23. Hu X, Beeton C: Detection of functional matrix metalloproteinases by zymography. J Vis Exp 2010; 45:2445.
24. Trampont P, Zhang L, Ravichandran KS: ShcA mediates the dominant pathway to extracellular signal-regulated kinase activation during early thymic development. Mol Cell Biol 2006; 26:9035-44.
25. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47:3239-45.
26. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K, Martin GR: Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 1982; 21:6188-93.
27. Terranova VP, Hujanen ES, Loeb DM, Martin GR, Thornburg L, Glushko V: Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cells. Proc Natl Acad Sci U S A 1986; 83:465-9.
28. Ludwig A, Petersen F, Zahn S, Götze O, Schröder JM, Flad HD, Brandt E: The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 1997; 90:4588-97.
29. Sykes DB, Kamps MP: Estrogen-dependent E2a/Pbx1 myeloid cell lines exhibit conditional differentiation that can be arrested by other leukemic oncoproteins. Blood 2001; 98: 2308-18.
30. Borsig L, Wong R, Hynes RO, Varki NM, Varki A: Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A 2002; 99: 2193-8.
31. Hart I: The spread of tumours. In: Knowles MA, ed. Introduction to the Cellular and Molecular Biology of Cancer, 4th ed. Oxford: Oxford University Press; 2007, pp 278-87.
32. Liu Z, Li L, Yang Z, Luo W, Li X, Yang H, Yao K, Wu B, Fang W: Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma. BMC Cancer 2010; 10:270.
33. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P: Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: A systematic review. Br J Cancer 2010; 102:1327-34.
34. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D: VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature 2005; 438:820-7.
35. Lucchinetti E, Ambrosio S, Aguirre J, Herrmann P, Härter L, Keel M, Meier T, Zaugg M: Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007; 106:262-8.
36. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J: Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001; 69:851-9.
37. Borregaard N, Cowland JB: Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 1997; 89: 3503-21.
38. Ahuja SK, Murphy PM: The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996; 271:20545-50.
39. Rose JJ, Foley JF, Murphy PM, Venkatesan S: On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2. J Biol Chem 2004; 279:24372-86.
40. Jones SA, Dewald B, Clark-Lewis I, Baggiolini M: Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2. J Biol Chem 1997; 272: 16166-9.
41. Nakagawara M, Takeshige K, Takamatsu J, Takahashi S, Yoshitake J, Minakami S: Inhibition of superoxide production and Ca2 mobilization in human neutrophils by halothane, enflurane, and isoflurane. Anesthesiology 1986; 64:4-12.
42. Lawson MA, Maxfield FR: Ca(2)-and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 1995; 377:75-9.
43. Gong Y, Hart E, Shchurin A, Hoover-Plow J: Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest 2008; 118:3012-24.
44. Sun HC, Qiu ZJ, Liu J, Sun J, Jiang T, Huang KJ, Yao M, Huang C: Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol 2007; 30:1359-67.
45. Sun L, Diamond ME, Ottaviano AJ, Joseph MJ, Ananthanarayan V, Munshi HG: Transforming growth factor-beta 1 promotes matrix metalloproteinase-9-mediated oral cancer invasion through snail expression. Mol Cancer Res 2008; 6:10-20.
46. Yue T, Roth Z'graggen B, Blumenthal S, Neff SB, Reyes L, Booy C, Steurer M, Spahn DR, Neff TA, Schmid ER, Beck-Schimmer B: Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro. Eur Respir J 2008; 31:118-25.
47. Urner M, Limbach LK, Herrmann IK, Müller-Edenborn B, Roth-Z'graggen B, Schlicker A, Reyes L, Booy C, Hasler M, Stark WJ, Beck-Schimmer B: Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury. Am J Respir Cell Mol Biol 2011; 45:617-24.
48. Steurer M, Schläpfer M, Z'graggen BR, Booy C, Reyes L, Spahn DR, Beck-Schimmer B: The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages. Clin Exp Immunol 2009; 155:224-30.
49. Suter D, Spahn DR, Blumenthal S, Reyes L, Booy C, Z'graggen BR, Beck-Schimmer B: The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells Anesth Analg 2007; 104:638-45